RESUMEN
The long-term increased cardiovascular risk of patients with an acute coronary syndrome (ACS) is a challenging and common clinical problem. Recent evidence demonstrated an ischemic benefit for a prolonged dual antiplatelet therapy beyond the initial 12 months at the cost of an increased bleeding risk. Individual, careful and repeated risk-benefit analyses are essential for an optimized patient management in which cardiovascular rehabilitation providers may play a central role.
Asunto(s)
Síndrome Coronario Agudo , Rehabilitación Cardiaca , Inhibidores de Agregación Plaquetaria/uso terapéutico , Síndrome Coronario Agudo/sangre , Síndrome Coronario Agudo/complicaciones , Humanos , Medición de Riesgo , Prevención SecundariaRESUMEN
2008 new guidelines for the management of patients with ST-elevation myocardial infarction were published by the European Society of Cardiology. For daily clinical practice, changes in recommendations concerning the preferred revascularization therapy according to different time delays are of great interest. This review focuses on possible implications of these new guidelines on the choice of reperfusion strategies in rural areas.